Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics Signs on FPN, Expanding its Payor Network

NEW YORK (GenomeWeb News) – Response Genetics today announced it has signed a contract that provides the 4.1 million members in Fortified Provider Network access to Response Genetics' molecular predictive tests.

Based in Scottsdale, Ariz., FPN is a direct-contracted network of preferred providers. As a result of today's deal, FPN members associated with more than 200 health insurers, self-funded employers, and other payors of healthcare services will be able to access Response Genetics' tests at discounted rates.

The deal is the seventh such agreement reached by Los Angeles-based Response Genetics this year and brings the total number of patients with access to the company's tests to 97 million. Last week, it announced a contract with preferred provider organization Three Rivers Provider Network.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.